RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma

Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. The standard treatment achieves a median overall survival for GBM patients of only 15 months. Hence, novel therapies based on an increased understanding of the mechanistic underpinnings of GBM are desperate...

Full description

Bibliographic Details
Main Authors: Jiesi Zhou, Yan Shu Kong, Krista M. Vincent, Dylan Dieters‐Castator, Amirali B. Bukhari, Darryl Glubrecht, Rong‐Zong Liu, Douglas Quilty, Scott D. Findlay, Xiaowei Huang, Zhihua Xu, Rui Zhe Yang, Lanyue Zhang, Emily Tang, Gilles Lajoie, David D. Eisenstat, Armin M. Gamper, Richard Fahlman, Roseline Godbout, Lynne‐Marie Postovit, YangXin Fu
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.13434
_version_ 1797690647058055168
author Jiesi Zhou
Yan Shu Kong
Krista M. Vincent
Dylan Dieters‐Castator
Amirali B. Bukhari
Darryl Glubrecht
Rong‐Zong Liu
Douglas Quilty
Scott D. Findlay
Xiaowei Huang
Zhihua Xu
Rui Zhe Yang
Lanyue Zhang
Emily Tang
Gilles Lajoie
David D. Eisenstat
Armin M. Gamper
Richard Fahlman
Roseline Godbout
Lynne‐Marie Postovit
YangXin Fu
author_facet Jiesi Zhou
Yan Shu Kong
Krista M. Vincent
Dylan Dieters‐Castator
Amirali B. Bukhari
Darryl Glubrecht
Rong‐Zong Liu
Douglas Quilty
Scott D. Findlay
Xiaowei Huang
Zhihua Xu
Rui Zhe Yang
Lanyue Zhang
Emily Tang
Gilles Lajoie
David D. Eisenstat
Armin M. Gamper
Richard Fahlman
Roseline Godbout
Lynne‐Marie Postovit
YangXin Fu
author_sort Jiesi Zhou
collection DOAJ
description Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. The standard treatment achieves a median overall survival for GBM patients of only 15 months. Hence, novel therapies based on an increased understanding of the mechanistic underpinnings of GBM are desperately needed. In this study, we show that elevated expression of 28S rRNA (cytosine‐C(5))‐methyltransferase NSUN5, which methylates cytosine 3782 of 28S rRNA in GBM cells, is strongly associated with the poor survival of GBM patients. Moreover, we demonstrate that overexpression of NSUN5 increases protein synthesis in GBM cells. NSUN5 knockdown decreased protein synthesis, cell proliferation, sphere formation, migration, and resistance to temozolomide in GBM cell lines. NSUN5 knockdown also decreased the number and size of GBM neurospheres in vitro. As a corollary, mice harboring U251 tumors wherein NSUN5 was knocked down survived longer than mice harboring control tumors. Taken together, our results suggest that NSUN5 plays a protumorigenic role in GBM by enabling the enhanced protein synthesis requisite for tumor progression. Accordingly, NSUN5 may be a hitherto unappreciated target for the treatment of GBM.
first_indexed 2024-03-12T02:02:20Z
format Article
id doaj.art-919b27202fed43f09567395980a0f763
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-03-12T02:02:20Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-919b27202fed43f09567395980a0f7632023-09-07T10:57:03ZengWileyMolecular Oncology1574-78911878-02612023-09-011791763178310.1002/1878-0261.13434RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastomaJiesi Zhou0Yan Shu Kong1Krista M. Vincent2Dylan Dieters‐Castator3Amirali B. Bukhari4Darryl Glubrecht5Rong‐Zong Liu6Douglas Quilty7Scott D. Findlay8Xiaowei Huang9Zhihua Xu10Rui Zhe Yang11Lanyue Zhang12Emily Tang13Gilles Lajoie14David D. Eisenstat15Armin M. Gamper16Richard Fahlman17Roseline Godbout18Lynne‐Marie Postovit19YangXin Fu20Department of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Biochemistry Western University London ON CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Biochemistry Western University London ON CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Biochemistry, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaDepartment of Oncology, Faculty of Medicine and Dentistry University of Alberta Edmonton AB CanadaGlioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. The standard treatment achieves a median overall survival for GBM patients of only 15 months. Hence, novel therapies based on an increased understanding of the mechanistic underpinnings of GBM are desperately needed. In this study, we show that elevated expression of 28S rRNA (cytosine‐C(5))‐methyltransferase NSUN5, which methylates cytosine 3782 of 28S rRNA in GBM cells, is strongly associated with the poor survival of GBM patients. Moreover, we demonstrate that overexpression of NSUN5 increases protein synthesis in GBM cells. NSUN5 knockdown decreased protein synthesis, cell proliferation, sphere formation, migration, and resistance to temozolomide in GBM cell lines. NSUN5 knockdown also decreased the number and size of GBM neurospheres in vitro. As a corollary, mice harboring U251 tumors wherein NSUN5 was knocked down survived longer than mice harboring control tumors. Taken together, our results suggest that NSUN5 plays a protumorigenic role in GBM by enabling the enhanced protein synthesis requisite for tumor progression. Accordingly, NSUN5 may be a hitherto unappreciated target for the treatment of GBM.https://doi.org/10.1002/1878-0261.13434glioblastomaNSUN5protein synthesisRNA cytosine methylation
spellingShingle Jiesi Zhou
Yan Shu Kong
Krista M. Vincent
Dylan Dieters‐Castator
Amirali B. Bukhari
Darryl Glubrecht
Rong‐Zong Liu
Douglas Quilty
Scott D. Findlay
Xiaowei Huang
Zhihua Xu
Rui Zhe Yang
Lanyue Zhang
Emily Tang
Gilles Lajoie
David D. Eisenstat
Armin M. Gamper
Richard Fahlman
Roseline Godbout
Lynne‐Marie Postovit
YangXin Fu
RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
Molecular Oncology
glioblastoma
NSUN5
protein synthesis
RNA cytosine methylation
title RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
title_full RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
title_fullStr RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
title_full_unstemmed RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
title_short RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
title_sort rna cytosine methyltransferase nsun5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
topic glioblastoma
NSUN5
protein synthesis
RNA cytosine methylation
url https://doi.org/10.1002/1878-0261.13434
work_keys_str_mv AT jiesizhou rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT yanshukong rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT kristamvincent rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT dylandieterscastator rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT amiralibbukhari rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT darrylglubrecht rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT rongzongliu rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT douglasquilty rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT scottdfindlay rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT xiaoweihuang rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT zhihuaxu rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT ruizheyang rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT lanyuezhang rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT emilytang rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT gilleslajoie rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT daviddeisenstat rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT arminmgamper rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT richardfahlman rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT roselinegodbout rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT lynnemariepostovit rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma
AT yangxinfu rnacytosinemethyltransferasensun5promotesproteinsynthesisandtumorigenicphenotypesinglioblastoma